Literature DB >> 32734714

Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.

Abdellatif Bouayad1,2.   

Abstract

SARS-CoV-2 virus, a member of the Coronaviridae family, causes Covid-19 pandemic disease with severe respiratory illness. Multiple strategies enable SARS-CoV-2 to eventually overcome antiviral innate immune mechanisms which are important components of viral pathogenesis. This review considers several mechanisms of SARS-CoV-2 innate immune evasion including suppression of IFN-α/β production at the earliest stage of infection, mechanisms that exhaust natural killer cell-mediated cytotoxicity, overstimulation of NLRP3 inflammasome and induction of a cytokine storm. A comparison with SARS-CoV is made. Greater knowledge of these and other immune evasion tactics may provide us with improved possibilities for research into this novel deadly virus.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Keywords:  IFN-α/β; NLRP3 inflammasome; SARS-CoV-2; coronaviruses; immune evasion; innate immunity

Year:  2020        PMID: 32734714     DOI: 10.1002/rmv.2135

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  20 in total

Review 1.  Two Years into the COVID-19 Pandemic: Lessons Learned.

Authors:  Severino Jefferson Ribeiro da Silva; Jessica Catarine Frutuoso do Nascimento; Renata Pessôa Germano Mendes; Klarissa Miranda Guarines; Caroline Targino Alves da Silva; Poliana Gomes da Silva; Jurandy Júnior Ferraz de Magalhães; Justin R J Vigar; Abelardo Silva-Júnior; Alain Kohl; Keith Pardee; Lindomar Pena
Journal:  ACS Infect Dis       Date:  2022-08-08       Impact factor: 5.578

Review 2.  The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2.

Authors:  Davide Ferrari; Michele Rubini; Jorge S Burns
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

Review 3.  Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction.

Authors:  Rahnuma Ahmad; Mainul Haque
Journal:  Vaccines (Basel)       Date:  2022-04-14

Review 4.  Features of HLA class I expression and its clinical relevance in SARS-CoV-2: What do we know so far?

Authors:  Abdellatif Bouayad
Journal:  Rev Med Virol       Date:  2021-04-01       Impact factor: 11.043

5.  Immune characteristics analysis reveals two key inflammatory factors correlated to the expressions of SARS-CoV-2 S1-specific antibodies.

Authors:  Shenglong Li; Wang Wang; Tingting Li; Xiaojian Han; Chao Hu; Yingming Wang; Meiying Shen; Li Du; Yaru Nai; Jianwei Wang; Aishun Jin
Journal:  Genes Dis       Date:  2020-12-23

Review 6.  Advances in immunotherapy for COVID-19: A comprehensive review.

Authors:  Masoomeh Masoomikarimi; Behzad Garmabi; Javad Alizadeh; Erfan Kazemi; Amirhossein Azari Jafari; Seyyedmohammadsadeq Mirmoeeni; Motahareh Dargahi; Niloofar Taheri; Reza Jafari
Journal:  Int Immunopharmacol       Date:  2021-01-22       Impact factor: 5.714

7.  Ross River Virus Immune Evasion Strategies and the Relevance to Post-viral Fatigue, and Myalgic Encephalomyelitis Onset.

Authors:  Brett A Lidbury
Journal:  Front Med (Lausanne)       Date:  2021-03-24

8.  Strategies for the Production of Soluble Interferon-Alpha Consensus and Potential Application in Arboviruses and SARS-CoV-2.

Authors:  Felipe Grabarz; Alexandre Paulo Yague Lopes; Flávia Ferreira Barbosa; Giovana Cappio Barazzone; Jademilson Celestino Santos; Viviane Fongaro Botosso; Soraia Attie Calil Jorge; Ana Lucia Tabet Oller Nascimento; Renato Mancini Astray; Viviane Maimoni Gonçalves
Journal:  Life (Basel)       Date:  2021-05-21

9.  Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients.

Authors:  Jeffrey E Gold; William H Baumgartl; Ramazan A Okyay; Warren E Licht; Paul L Fidel; Mairi C Noverr; Larry P Tilley; David J Hurley; Balázs Rada; John W Ashford
Journal:  mBio       Date:  2020-11-20       Impact factor: 7.867

10.  Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis.

Authors:  Wanvisa Udomsinprasert; Jiraphun Jittikoon; Sermsiri Sangroongruangsri; Usa Chaikledkaew
Journal:  J Clin Immunol       Date:  2020-10-31       Impact factor: 8.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.